Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04039750 · ClinicalTrials.gov registry record · Phase 2

Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis

A Phase 2 study of Perforated Appendicitis, sponsored by Prisma Health-Upstate.

Active
Registry status
Phase 2
Development phase
200
Enrollment target
1
Study location

NCT04039750 is a Phase 2 study of Perforated Appendicitis that is active but no longer recruiting, run by Prisma Health-Upstate. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04039750, a Phase 2 study of Perforated Appendicitis, is active but no longer recruiting, sponsored by Prisma Health-Upstate.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The proposed study will investigate whether antibiotic irrigation using a gentamicin/clindamycin solution during laparoscopic appendectomy is superior in preventing postoperative wound infections and IAA in perforated appendicitis compared to suction without irrigation. This will be the first prospective study to compare these two options in pediatric PA.

Conditions Studied

Interventions

  • DRUG antibiotic rinse with suction
  • PROCEDURE suction only

Study Locations (1)

South Carolina

  • Prisma Health - Upstate - Greenville

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-07-25
Est. Completion 2026-12
Phase Phase 2

Sponsor

Prisma Health-Upstate

67 total trials

What the Registry Record Tells You About NCT04039750

The ClinicalTrials.gov registry entry for NCT04039750 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Perforated Appendicitis appearing as the primary indexed condition, and to 2 interventions - of which antibiotic rinse with suction is the first listed.

NCT04039750 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04039750 about?

NCT04039750 is a clinical study titled "Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis". The proposed study will investigate whether antibiotic irrigation using a gentamicin/clindamycin solution during laparoscopic appendectomy is superior in preventing postoperative wound infections and IAA in perforated appendicitis compared to suction without irrigation. This will be the first prospe...

What is the current status of trial NCT04039750?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2019-07-25. Estimated completion is 2026-12.

What conditions does trial NCT04039750 study?

This clinical trial studies the following conditions: Perforated Appendicitis.

What interventions are being tested in trial NCT04039750?

The interventions under investigation include: antibiotic rinse with suction (DRUG), suction only (PROCEDURE).

Who is sponsoring clinical trial NCT04039750?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04039750 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Perforated Appendicitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.